Medical Device News Magazine

Project for Futuristic Surgical Training Receives CHF 12 Million in Funding

Project for Futuristic Surgical Training Receives CHF 12 Million in Funding

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Surgical Training: Swiss Innovation Agency Innosuisse has awarded a grant of CHF 12 million over the next four years in support of the “PROFICIENCY” project for surgical simulation. The project initiates a paradigm shift in practical training in surgery: away from primary training in the operating room, towards standardized and proficiency-based surgical training curricula.

Thanks to technical advances in virtual and augmented reality, many surgical procedures can already be simulated with lifelike accuracy. However, practical training still frequently occurs in the operating room. The disadvantage of this form of training became obvious during the Covid 19 pandemic: surgical training was largely restricted or not possible at all in most hospitals during this time.

“With the ‘PROFICIENCY’ project, we want to advance simulator-based continuing education in surgery,” explains Prof. Bruno Schmied, M.D., Chief of Surgery at the Cantonal Hospital of St. Gallen. “The innovative continuing education program – analogous to the training and continuing education of pilots on flight simulators – will decisively improve surgical continuing education in open and minimally invasive surgery and initiate the desired paradigm shift to competence-oriented and didactically high-quality simulator-supported training.”

As a first decisive step, the project will design a modular curriculum that is aligned with the requirements of surgical societies and integrated on a digitally accessible learning platform. This standardized, evidence-based and performance-oriented training program will be taught using the latest didactic methods and empower surgeons to acquire skills through self-paced learning.

In a second major step, the consortium will develop innovative training tools for simulating different surgical scenarios, ranging from online virtual reality simulation, augmented box trainers, high-end simulators, to augmented-reality-enabled open surgery and immersive remote operation room participation.

“This flagship innovation project brings together the necessary medical, pedagogical and technical expertise to create the most advanced and comprehensive surgical training curriculum ever developed,” said Stefan Tuchschmid, PhD, co-CEO and founder of VirtaMed.

The consortium of project partners includes the Cantonal Hospital of St.Gallen, Lausanne University Hospital (CHUV), the University of Zurich with Balgrist University Hospital, ETH Zurich and Zurich University of Applied Sciences (ZHAW), as well as the companies VirtaMed AG, Microsoft Schweiz GmbH , ORamaVR S.A. and Atracsys LLC.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”